I don't know how anyone missed it, it's there clear as daylight there are 17 trials that are also moving through lab/field/pilot phase, one step away from sales? Texas was in Field Testing Phase and has quickly progressed through pilot into drum sales they possibly were happy with the 4% down to 2% result or they added extra more HCD to achieve the 1% which was commercially viable?
We will see 10+ sales imo this year, these companies have moved from opportunities being identified, proposals sent, lab testing field testing to finally pilot, seems each stage needs to pass before moving on to the next and if this is any evidence this company's MC is about to explode.
This is the most exciting part that shows China 38,000 x $3.78 = $4,309,200 per month, $12,927,600 per Quarter.....
Then we have these monsters waiting for field trial approval.....IF THEY DO ....I don't even want to writ the numbers down but I will
175,000x $2.83 (1500PPM average) = $44.5m per quarter.........Let's say they only ordered 500ppm $14.5m per quarter..
- Forums
- ASX - By Stock
- HCD
- Ann: Indago Makes Sales of Multi-Flow in Texas
Ann: Indago Makes Sales of Multi-Flow in Texas, page-5
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCD (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.425M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 65188 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 2962937 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 65188 | 0.003 |
11 | 8750710 | 0.002 |
8 | 8820003 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 2962937 | 3 |
0.005 | 2337160 | 4 |
0.006 | 137207 | 1 |
0.010 | 27700 | 1 |
0.011 | 103000 | 1 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
HCD (ASX) Chart |
Day chart unavailable